Using a Facebook chatbot to share health information
Part of Cancer, Immune system & allergy, Infections, Skin clinical trials.
This study tests whether a Facebook Messenger chatbot can provide helpful health information for different conditions. You may help researchers check if people can use the chatbot and understand the information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 14 or older
- Be able to read and understand English and/or French
- Be able to understand the study and say yes to participate (informed consent)
- Have access to a smartphone, tablet, or computer and the internet (or mobile data)
- Be willing to use a Facebook Messenger chatbot
- Have or be willing to create a personal Facebook account and agree to Facebook’s privacy rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help people who face barriers get routine mammograms. If you are going for a regular breast cancer screening, you may be able to join.
This study tests a chatbot that sends text messages to help Black women aged 40-74 schedule breast cancer screenings. It aims to increase screening rates by providing information and reminders in a friendly, accessible way.
This study uses a smartphone app and biological markers to predict cancer risk. It is testing whether digital and molecular data can help identify cancer earlier, especially in women with a history of certain cancers.
This study is testing a new AI chatbot that gives support after breast cancer treatment. If you join, you'll chat with the bot on Line to help with your recovery.
This study tests tools to help people talk with employers and medical staff about breast cancer treatment while working. It aims to improve how treatment and job needs are discussed so patients can get support.
This study tests a chatbot that offers support and advice for cancer survivors. If you're a young adult dealing with symptoms or side effects, this could help you manage them better.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.